Agilent Technologies Inc (A) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.

Total Cash From Operating Activities Chart for Agilent Technologies Inc

Agilent Technologies Inc (A) operating cash flow for FY2025 was USD 1.6B, a -11.0% change from FY2024. Agilent Technologies Inc's operating cash flow grew from USD 751.0M in 1998 to USD 1.6B in 2025 (107.6% over 27 years). Operating cash flow compound annual growth rate: 5-year CAGR of 11.1%, 10-year CAGR of 1.7%, 20-year CAGR of 2.8%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$43.80B
Implied Share Price
$155.08
Enterprise Value
$45.26B
Revenue (TTM)
$7.23B
EBITDA
$2.02B
Profit Margin
19.55%
Trailing P/E
31.08
Forward P/E
23.20
Price/Book (MRQ)
6.14
Price/Sales (TTM)
6.06
EV/EBITDA
23.07
EV/Revenue
6.26
Dividend Yield
0.65%
Book Value
$25.24
Free Cash Flow (FY2025)
$1.15B
Free Cash Flow Yield
2.63%

Snapshot as of 26th August 2026 — not point-in-time controlled, may lag the live market by a few days.